Last reviewed · How we verify
Comparator: Placebo matching RotaTeq™
This is a placebo comparator arm in a RotaTeq clinical trial, not an active drug.
This is a placebo comparator arm in a RotaTeq clinical trial, not an active drug. Used for Rotavirus gastroenteritis prevention (Phase 3 trial comparator).
At a glance
| Generic name | Comparator: Placebo matching RotaTeq™ |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Biologic |
| Therapeutic area | Immunology/Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
RotaTeq is a live attenuated rotavirus vaccine that provides immunization against rotavirus infection. The placebo matching RotaTeq would be an inert formulation designed to match the appearance and administration route of the active vaccine for blinded trial purposes. This entry describes the control arm rather than an active pharmaceutical agent.
Approved indications
- Rotavirus gastroenteritis prevention (Phase 3 trial comparator)
Common side effects
Key clinical trials
- A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED) (PHASE1)
- Dose Confirmation Efficacy Study (V260-007) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Comparator: Placebo matching RotaTeq™ CI brief — competitive landscape report
- Comparator: Placebo matching RotaTeq™ updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI